Teladoc Health Inc (NYSE:TDOC) posted upbeat results for the fourth quarter on Wednesday.
The company posted a quarterly loss of 14 cents per share, versus market estimates of a loss of 18 cents per share. The company’s sales came in at $642.269 million, beating estimates of $635.235 million.
Teladoc Health said it sees FY2026 GAAP loss of $(1.10)-$(0.70) vs market estimates of $(0.76). The company expects sales of $2.470 billion-$2.587 billion, versus estimates of $2.548 billion.
“We closed 2025 with a solid finish, delivering consolidated revenue and adjusted EBITDA above the midpoint of our guidance ranges for the fourth quarter. I’m encouraged by the progress we made last year against each of our strategic priorities, as we strengthened our product portfolio, advanced innovation across Integrated Care and BetterHelp, and positioned the company to build …